MedPath

The effect of Lansoprazole in the prevention of osteonecrosis of the femoral head in patients with immune diseases treated corticosteroid

Not Applicable
Conditions
non-traumatic osteonecrosis of the femoral head
Registration Number
JPRN-UMIN000017648
Lead Sponsor
Sapporo Medical University hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Current ONFH; hip joint disease requiring surgery; alcohol-abuse; dementia; past allergy to LPZ; treatment with atazanavir sulfate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of prevention efficacy of Lansoprazole using MRI.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath